Bioretec Reports FDA Grants Breakthrough Device Designation for Bioresorbable RemeOs™ Screw products
Under the Breakthrough Devices Program, FDA will enable an ongoing and prioritized interactive discussion between Bioretec and the authorities regarding the commercial access of RemeOs™ Screws in the U.S. market.
Intersect ENT EXPAND Post-Market Study Evaluating Longer-Term Outcomes of PROPEL® Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation
EXPAND is a prospective, randomized, single-blind, intra-patient controlled, post-market clinical trial enrolling approximately 80 patients in the United States.
Artio Medical Closes Tranche of $12 Million in Series A Financing
Company to accelerate clinical testing and prepare for commercialization of its broad portfolio of products.
Biotechnology News Magazine – Our Sister Publication
Biotechnology News Magazine is the “sister” publication to Medical Device News Magazine, a division of PTM Healthcare Marketing.
iCleanse Announces Collaboration with CIT to Offer Low-Interest Financing on All iCleanse Disinfection Products to Kill COVID
iCleanse can better serve its current and future customer base, who may have limited cash flow due to the year-long pandemic, making UV-C disinfection more attainable for small and large businesses alike and keeping businesses open.